Approval · Notice of Compliance 30385 · 2023
NETVISION: Notice of Compliance 30385
Issued March 21, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30385
- Date
- March 21, 2023
- Company
- University Health NetworkToronto, Ontario, Canada
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative ¿ Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NETVISION | 02525542 | Dormant |
Medicinal ingredients
- GALLIUM 68 GA OXODOTREOTIDE 122 MBQ per ML